Why Finance Teams Should Watch UAE R&D Tax Incentive Policy

The UAE has been signalling for some time that an R&D tax incentive is on the horizon. What’s changed recently is that the corporate tax framework has been actively updated to “make room” for future incentives, including a clearer ordering of how credits reduce corporate tax payable, and a formal mechanism to refund unused credits.

For finance teams, this matters because the difference between “a policy announcement” and “a usable incentive” is operational: how credits are calculated, applied, evidenced, booked, and ultimately recovered. The newest legislative amendments are not the R&D regime itself, but they are the plumbing that will allow an R&D credit to function in a controlled, auditable way once Cabinet Decisions and implementing guidance land.

This article explains what the new framework does, why it is relevant to the prospective UAE R&D tax credit, and how CFOs and accountants can prepare (systems, controls, documentation and governance) without waiting for the final rulebook.

What is the UAE signalling on R&D tax incentives?

Based on public consultation and official statements, the UAE has indicated it is considering an R&D tax incentive that would:

• Apply for tax periods starting on or after 1 January 2026 (as currently proposed).

• Be expenditure-based, with a potential 30–50% tax credit.

• Potentially be refundable, with refundability linked (in the proposals) to factors such as UAE revenue and number of UAE employees.

• Align qualifying R&D definitions to the OECD Frascati Manual and require the activity to be conducted within the UAE.

Those signals are important, but the operational question for CFOs is: how would such a credit be settled against corporate tax, and what happens if the credit exceeds the liability? That’s where the recent amendments come in.

The “readiness” legislation: what Federal Decree-Law No. 28 of 2025 actually changes

Recent changes via Federal Decree-Law No. 28 of 2025 amend the UAE Corporate Tax Law (Federal Decree-Law No. 47 of 2022) in two key ways that are directly relevant to future incentives:

1. A revised Article 44 that sets out a sequence for settling corporate tax payable using credits and, importantly, makes explicit room for future Cabinet-specified incentives/reliefs.

2. A new Article 49 bis that establishes the right (subject to conditions/procedures) to claim a refund/payment for unused tax credits arising from incentives and reliefs.

Think of this as the corporate tax system adding a standard interface: “If a Cabinet Decision creates a credit, here is where it sits in the calculation and here is how excess can be refunded.”

Article 44: the settlement order finance teams must model in their tax engine

Under the amended framework, corporate tax payable is settled sequentially. The sequence (as summarised in official and practitioner commentary) is broadly:

1. Apply withholding tax credits (where applicable).

2. Apply foreign tax credits.

3. Apply other credits/incentives/reliefs specified by Cabinet Decision (on the suggestion of the Minister).

4. Pay any remaining corporate tax under normal payment rules.

Why this matters for an eventual UAE R&D tax credit

If (as expected) the R&D incentive is delivered as a tax credit, it will sit in step 3 above, i.e., after foreign tax credits, and as part of a category that depends on future Cabinet Decisions.

For CFOs, this is more than a legal sequencing point. It affects:

• Forecasting: the order determines what “uses up” liability first.

• Tax provisioning: the location of the credit in the waterfall affects current tax expense and cash tax expectations.

• Systems design: your tax calculation logic (and supporting schedules) must be able to compute and apply credits in the correct statutory order.

Even where withholding tax is currently 0% in practice, the legislative ordering still matters because it governs how the corporate tax return and any refund claim could be expected to behave in a future audit trail. 

Article 49 bis: why “refundability” is the game-changer (and the compliance burden)

Historically, refund scenarios were narrow (e.g., overpayment). The new Article 49 bis expands the framework so that unused credits arising from incentives/reliefs can, in certain cases, be claimed as a payment/refund, subject to conditions, timeframes and procedures to be set out via Cabinet Decision. 

Practical implications CFOs should take seriously

Refundability is not just “nice for cash flow”; it typically drives:

• Higher evidentiary standards (refund claims attract scrutiny).

• Stricter process controls (approval workflows, audit trails, sign-offs).

• Greater need for clean, reconcilable data (from GL → subledgers → project accounting → payroll).

• Potential timing complexity (when a credit becomes claimable, when it becomes refundable, and how long recovery takes, all likely to be specified later).

The legislation also contemplates the tax authority operationally funding refunds (e.g., ability to withhold amounts from tax revenues for settling approved claims, subject to governance). 

In other words, the UAE is building the mechanism to support refunds, but finance teams should assume that “refund-ready” also means “audit-ready.”

What will actually define the UAE R&D tax credit? (What we know vs what will come later)

A key technical point: Federal Decree-Law No. 28 of 2025 does not itself define the incentive. It establishes the framework by which incentives can be introduced and administered.

Known / signalled elements (based on official statements)

• Expenditure-based design.

• Potential 30–50% rate range.

• Proposed start for tax periods from 1 January 2026.

• Potential refundability linked to UAE revenue and UAE headcount.

• OECD Frascati alignment; activity conducted within the UAE.

Still expected via Cabinet Decisions / guidance

• Exact definition of qualifying R&D activities and exclusions.

• Eligible cost categories and treatment of mixed-use costs.

• Interaction with related-party arrangements, subcontracting, and cross-border work.

• How to evidence “conducted within the UAE”.

• The controls, timeframes and procedures for claiming refunds under Article 49 bis.

From a CFO standpoint: the “unknowns” are largely the parts that determine the complexity of implementation. The best preparation is to ensure your organisation can produce high-integrity, decision-useful R&D cost and activity data.

The technical “shape” of an R&D credit: what your finance function should design for

Even before the final incentive rules are issued, finance teams can anticipate the likely architecture because the UAE has clearly positioned the incentive as credit-based and potentially refundable.

1) A robust R&D cost taxonomy (aligned to how you actually build products/services)

Most failed incentive processes break at the classification layer. You need a cost taxonomy that is:

• Consistent: the same cost type is treated the same way every month.

• Explainable: you can map costs to projects and to qualifying activities.

• Auditable: you can reconcile totals back to trial balance and statutory accounts.

Sector-agnostic doesn’t mean “generic”. A healthcare group, a logistics business, and a software company all do R&D differently, but each needs a defensible methodology for identifying innovation spend.

2) A project/activity model that can withstand a technical review

Because the UAE has signalled alignment with the Frascati Manual, you should expect definitions that focus on:

• Novelty / advancement (not just routine engineering)

• Uncertainty and systematic investigation

• Documented hypotheses, experimentation, iteration

• Traceability from activity to outcomes

The finance function doesn’t need to become the science team, but it does need a repeatable way to translate technical activity into a claim-ready narrative and evidence pack.

3) A “credit ledger” approach, not a one-off spreadsheet

Once credits can be carried, offset, and potentially refunded, you are effectively managing a new tax attribute with a lifecycle:

• Recognition / computation

• Application in statutory order (Article 44)

• Tracking unused balances

• Refund eligibility (Article 49 bis conditions)

• Submission and recovery

• Post-claim enquiry / audit support

CFOs should treat this like managing deferred tax attributes or foreign tax credit pools: structured schedules, controlled inputs, and strong governance.

Controls and governance: the part tax incentives rarely forgive

Refundable incentives typically place finance teams under a different audit lens. The aim should be “controls by design”, including:

Policy controls

• A documented R&D definition and boundary policy (what is in/out, and why).

• A cost eligibility policy (capital vs revenue, direct vs indirect, allocations).

• A location policy (how you evidence UAE-based activity).

Process controls

• A monthly or quarterly R&D cost capture process (not annual panic).

• Maker-checker approvals over project classification and allocations.

• Controlled changes to mapping rules and rate assumptions.

Evidence controls

• Version-controlled supporting documentation.

• Documented link from qualifying activities → cost pools → GL balances.

• Retention protocols aligned to expected enquiry windows.

Even without the final UAE guidance, this control framework gives you resilience: when Cabinet Decisions arrive, you adjust rules, not rebuild the entire process.

Systems implications: what to review now in ERP, payroll and project accounting

If you want to be ready to claim efficiently (and defend confidently), you typically need to align three systems domains:

1) General ledger and chart of accounts

• Do you have cost centres / dimensions that can separate innovation workstreams?

• Can you tag costs to “R&D candidate” vs “non-R&D” without manual workarounds?

• Are capitalised development costs tracked separately from revenue spend (and can you report both)?

2) Payroll and HR data

Given the incentive is signalled as expenditure-based and may include labour costs (details to come), you should be able to extract:

• Employee cost by role, location, and project

• Time allocation methodology (if required) that is realistic and defensible

• UAE headcount metrics (noting refundability may reference employee numbers)

3) Project accounting / time recording

If you don’t have project accounting today, you don’t necessarily need enterprise-grade tooling tomorrow, but you do need:

• A consistent project list and ownership model

• The ability to link invoices, POs and payroll allocations to projects

• A narrative evidence layer (what was attempted, what changed, what was learned)

This is where many businesses in fast-moving sectors (including healthcare innovators) struggle: the work is real, but the records are scattered. That becomes expensive at claim time.

Interactions with global minimum tax (Pillar Two): why multinationals need to model credit characterisation

If you are part of an in-scope multinational group (or you expect to be), the character of an R&D tax credit can affect your Pillar Two effective tax rate (ETR) computations.

Practitioner analysis highlights that refundable credits may be treated differently depending on whether they qualify as “qualified refundable” credits (e.g., cash availability within a specified period) or other categories — impacting whether the benefit reduces covered taxes or is treated more like income for ETR purposes. 

The key CFO takeaway: it will not be enough to ask “how much credit do we get?” You will also need to ask “how does this credit behave under Pillar Two modelling, and does it increase domestic top-up exposure?”

This is especially relevant in groups operating across multiple jurisdictions where incentive design can unintentionally shift tax cost from one place to another.

A CFO checklist: “claim-ready” preparation for UAE R&D tax credits

Here is a practical readiness checklist you can action now, without waiting for final Cabinet Decisions:

1. Inventory innovation activity

   • Identify programmes/projects that plausibly meet an OECD-aligned R&D definition.

2. Build a cost mapping

   • Map cost types to candidate categories; decide what evidence supports each.

3. Implement tagging in finance systems

   • Add dimensions/codes to capture R&D candidate spend as business-as-usual.

4. Define governance

   • Assign ownership across finance, tax, and operational leadership; set sign-off points.

5. Stand up an evidence pack

   • Standard templates for project summaries, uncertainties, iterations, and outcomes.

6. Design the “credit waterfall” logic

   • Prepare tax schedules that apply credits in the statutory order (Article 44) and track unused balances.

7. Plan refund readiness

   • Assume refund claims will require higher documentation standards; ensure retention and reconciliation.

8. Model Pillar Two exposure (if relevant)

   • Scenario-test the effect of refundable credits on group ETR and top-up positions.

This approach turns the eventual incentive into a controlled finance process, rather than a one-off scramble.

Why this is particularly relevant in Dubai and Abu Dhabi

In practice, many innovation-heavy groups centralise finance leadership, shared services, and investment decision-making in Dubai or Abu Dhabi, even where operations span multiple Emirates. For CFOs in these centres, the challenge is ensuring that:

• UAE-based R&D activity is demonstrably within scope (once defined)

• Spending can be traced to UAE activity

• Documentation is consistent across business units and entities

That’s less about geography and more about governance and data discipline, but these hubs are often where the incentives strategy will be managed.

Sources and legal note

This article reflects publicly available commentary and official statements on the proposed incentive and the recent Corporate Tax amendments. The detailed R&D regime and refund process will depend on forthcoming Cabinet Decisions and implementing guidance.